209 related articles for article (PubMed ID: 12545689)
21. Comparative penetration of moxifloxacin and gatifloxacin in rabbit aqueous humor after topical dosing.
Levine JM; Noecker RJ; Lane LC; Herrygers L; Nix D; Snyder RW
J Cataract Refract Surg; 2004 Oct; 30(10):2177-82. PubMed ID: 15474833
[TBL] [Abstract][Full Text] [Related]
22. The penetration of oral ciprofloxacin into the aqueous humor, vitreous, and subretinal fluid of humans.
Lesk MR; Ammann H; Marcil G; Vinet B; Lamer L; Sebag M
Am J Ophthalmol; 1993 May; 115(5):623-8. PubMed ID: 8488915
[TBL] [Abstract][Full Text] [Related]
23. Human aqueous humor concentrations of besifloxacin, moxifloxacin, and gatifloxacin after topical ocular application.
Donnenfeld ED; Comstock TL; Proksch JW
J Cataract Refract Surg; 2011 Jun; 37(6):1082-9. PubMed ID: 21596251
[TBL] [Abstract][Full Text] [Related]
24. Vitreous and aqueous penetration of orally and topically administered moxifloxacin.
Fukuda M; Shibata N; Osada H; Yamashiro Y; Sasaki H
Ophthalmic Res; 2011; 46(3):113-7. PubMed ID: 21325873
[TBL] [Abstract][Full Text] [Related]
25. Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given in different concentrations in a wick before cataract surgery.
Ong-Tone L
J Cataract Refract Surg; 2008 May; 34(5):819-22. PubMed ID: 18471639
[TBL] [Abstract][Full Text] [Related]
26. Vitreal penetration of oral moxifloxacin in humans.
Lott MN; Fuller JJ; Hancock HA; Singh J; Singh H; McGwin G; Marcus DM
Retina; 2008 Mar; 28(3):473-6. PubMed ID: 18327141
[TBL] [Abstract][Full Text] [Related]
27. Vitreous and aqueous penetration of orally administered gatifloxacin in humans.
Fuller JJ; Marcus DM
Arch Ophthalmol; 2004 Sep; 122(9):1408-9; author reply 1409. PubMed ID: 15364732
[No Abstract] [Full Text] [Related]
28. The effect of cataract surgery on ocular levels of topical moxifloxacin.
Mather R; Stewart JM; Prabriputaloong T; Wong J; McLeod SD
Am J Ophthalmol; 2004 Oct; 138(4):554-9. PubMed ID: 15488780
[TBL] [Abstract][Full Text] [Related]
29. The ocular penetration of oral sparfloxacin in humans.
Bron AM; Pechinot AP; Garcher CP; Guyonnet GA; Kazmierczak AM; Schott DA; Lecoeur H
Am J Ophthalmol; 1994 Mar; 117(3):322-7. PubMed ID: 8129004
[TBL] [Abstract][Full Text] [Related]
30. Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor.
Solomon R; Donnenfeld ED; Perry HD; Snyder RW; Nedrud C; Stein J; Bloom A
Ophthalmology; 2005 Mar; 112(3):466-9. PubMed ID: 15745775
[TBL] [Abstract][Full Text] [Related]
31. Effect of gatifloxacin ophthalmic solution 0.3% on human corneal endothelial cell density and aqueous humor gatifloxacin concentration.
Price MO; Quillin C; Price FW
Curr Eye Res; 2005 Jul; 30(7):563-7. PubMed ID: 16020290
[TBL] [Abstract][Full Text] [Related]
32. Penetration of ofloxacin in human aqueous and vitreous humors following oral and topical administration.
Cekic O; Batman C; Yasar U; Basci NE; Bozkurt A; Kayaalp SO
Retina; 1998; 18(6):521-5. PubMed ID: 9869460
[TBL] [Abstract][Full Text] [Related]
33. Comparative intraocular penetration of 4 fluoroquinolones after topical instillation.
Chung JL; Lim EH; Song SW; Kim BY; Lee JH; Mah FS; Seo KY
Cornea; 2013 Jul; 32(7):1046-51. PubMed ID: 23615274
[TBL] [Abstract][Full Text] [Related]
34. Intracorneal, aqueous humor, and vitreous humor penetration of topical and oral ofloxacin.
Donnenfeld ED; Perry HD; Snyder RW; Moadel R; Elsky M; Jones H
Arch Ophthalmol; 1997 Feb; 115(2):173-6. PubMed ID: 9046250
[TBL] [Abstract][Full Text] [Related]
35. Aqueous humour penetration of moxifloxocin and gatifloxacin eye drops in different dosing regimens before phacoemulsification surgery.
Güngör SG; Akova YA; Bozkurt A; Yasar Ü; Babaoğlu MÖ; Çetinkaya A; Çolak M
Br J Ophthalmol; 2011 Sep; 95(9):1272-5. PubMed ID: 21030410
[TBL] [Abstract][Full Text] [Related]
36. Aqueous and vitreous penetration of levofloxacin after topical and/or oral administration.
Sakamoto H; Sakamoto M; Hata Y; Kubota T; Ishibashi T
Eur J Ophthalmol; 2007; 17(3):372-6. PubMed ID: 17534819
[TBL] [Abstract][Full Text] [Related]
37. Vitreal penetration of oral and topical moxifloxacin in humans.
Fuller JJ; Lott MN; Henson NM; Bhatti AA; Singh H; McGwin G; Marcus DM
Am J Ophthalmol; 2007 Feb; 143(2):338-40. PubMed ID: 17258525
[TBL] [Abstract][Full Text] [Related]
38. Vitreous penetration of orally administered valacyclovir.
Huynh TH; Johnson MW; Comer GM; Fish DN
Am J Ophthalmol; 2008 Apr; 145(4):682-6. PubMed ID: 18226802
[TBL] [Abstract][Full Text] [Related]
39. Ocular penetration and pharmacokinetics of topical gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions after keratoplasty.
Holland EJ; Lane SS; Kim T; Raizman M; Dunn S
Cornea; 2008 Apr; 27(3):314-9. PubMed ID: 18362660
[TBL] [Abstract][Full Text] [Related]
40. Comparison of corneal and aqueous humor penetration of moxifloxacin, gatifloxacin and levofloxacin during keratoplasty.
Fukuda M; Yamada M; Kinoshita S; Inatomi T; Ohashi Y; Uno T; Shimazaki J; Satake Y; Maeda N; Hori Y; Nishida K; Kubota A; Nakazawa T; Shimomura Y
Adv Ther; 2012 Apr; 29(4):339-49. PubMed ID: 22529026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
